Skip to content
drillr.ai
Sign up

CORT

CORCEPT THERAPEUTICS INC

NASDAQ · Healthcare · Biotechnology · US

$110.29
−3.98%
Ask drillr
0
Insider buys (3m)
60
Insider sells (3m)
-$56.2M
Net value (3m)
+42.8%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 18, 2026Robb Gary Charles · officer: Chief Business OfficerM-Exempt17,493$8.27
Sep 18, 2026Vieira Roberto Wandenkolk · officer: President, OncologySale296$101
Sep 16, 2026Lyon Joseph Douglas · officer: See RemarksSale7,812$113
Sep 16, 2026WILSON JAMES N · directorSale2,800$112
Sep 16, 2026WILSON JAMES N · directorSale6,800$110
Sep 16, 2026Lyon Joseph Douglas · officer: See RemarksM-Exempt2,596$11
Sep 16, 2026WILSON JAMES N · directorSale400$111
Sep 16, 2026Lyon Joseph Douglas · officer: See RemarksSale2,188$114
Sep 16, 2026Lyon Joseph Douglas · officer: See RemarksM-Exempt7,404$14
Sep 3, 2026Vieira Roberto Wandenkolk · officer: President, OncologySale974$112
Sep 3, 2026Vieira Roberto Wandenkolk · officer: President, OncologyF-InKind102$113
Sep 3, 2026Robb Gary Charles · officer: Chief Business OfficerF-InKind91$113
Sep 3, 2026Maduck Sean · officer: See RemarksSale11,730$114
Sep 3, 2026Vieira Roberto Wandenkolk · officer: President, OncologyA-Award138$113
Sep 3, 2026Vieira Roberto Wandenkolk · officer: President, OncologySale23,600$109
Sep 3, 2026Vieira Roberto Wandenkolk · officer: President, OncologySale23,770$111
Sep 3, 2026Maduck Sean · officer: See RemarksSale10,989$115
Sep 3, 2026Mokari Atabak · officer: Chief Financial OfficerA-Award138$113
Sep 3, 2026Vieira Roberto Wandenkolk · officer: President, OncologyM-Exempt58,333$22
Sep 3, 2026Maduck Sean · officer: See RemarksM-Exempt25,000$8.27
Sep 3, 2026Robb Gary Charles · officer: Chief Business OfficerA-Award164$113
Sep 3, 2026Maduck Sean · officer: See RemarksSale2,281$116
Sep 3, 2026Lyon Joseph Douglas · officer: See RemarksA-Award130$113
Sep 3, 2026Mokari Atabak · officer: Chief Financial OfficerF-InKind102$113
Sep 3, 2026Vieira Roberto Wandenkolk · officer: President, OncologySale1,606$114
Sep 3, 2026Guyer William · officer: Chief Development OfficerA-Award164$113
Sep 3, 2026Lyon Joseph Douglas · officer: See RemarksF-InKind72$113
Sep 3, 2026Vieira Roberto Wandenkolk · officer: President, OncologySale1,225$115
Sep 3, 2026Maduck Sean · officer: See RemarksA-Award150$113
Sep 3, 2026Vieira Roberto Wandenkolk · officer: President, OncologySale5,621$115
Institutional positioning

13F filings over the trailing two quarters

New 198Increased 259Reduced 246Sold out 50
FilerActionSharesFiled
BlackRock, Inc.Increased12,432,023Aug 7, 2026
BLACKROCK, INC.Increased12,151,276May 13, 2026
INGALLS & SNYDER LLCIncreased7,947,007Aug 14, 2026
INGALLS & SNYDER LLCIncreased7,611,916May 13, 2026
RENAISSANCE TECHNOLOGIES LLCReduced5,682,783May 14, 2026
RENAISSANCE TECHNOLOGIES LLCReduced5,261,628Aug 13, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCIncreased5,044,638Aug 13, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position4,820,568May 8, 2026
VANGUARD CAPITAL MANAGEMENT LLCIncreased4,172,482Aug 13, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position4,077,196May 15, 2026
PARALLEL ADVISORS, LLCIncreased3,977,404Jun 3, 2026
Parallel Advisors, LLCReduced3,962,177Aug 5, 2026
FMR LLCIncreased3,337,618Aug 13, 2026
STATE STREET CORPIncreased3,279,381Aug 7, 2026
STATE STREET CORPIncreased3,200,946May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 18, 2026